On December 5, 2023, Renee Tannenbaum, a director of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), executed a transaction involving the sale of 1,800 shares of...
Shares of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) have received an average recommendation of “Buy” from ten research firms, according to MarketBeat. The consensus target...